Tempus AI (TEM) to Release Quarterly Earnings on Thursday

Tempus AI (NASDAQ:TEM) is anticipated to announce its Q2 2026 results before the market opens on Thursday, July 30th. Analysts expect the company to post earnings of ($0.13) per share and revenue of $379.6870 million for the quarter. Parties may visit the the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 30, 2026 at 4:30 PM ET.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings results on Tuesday, May 5th. The company reported ($0.13) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.08. The firm had revenue of $348.12 million for the quarter, compared to analysts’ expectations of $345.44 million. Tempus AI had a negative net margin of 22.20% and a negative return on equity of 53.83%. The firm’s revenue for the quarter was up 36.1% compared to the same quarter last year. During the same quarter last year, the company earned ($0.24) EPS. On average, analysts expect Tempus AI to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Tempus AI Price Performance

TEM traded down $0.69 during midday trading on Wednesday, hitting $42.22. 1,141,776 shares of the company traded hands, compared to its average volume of 5,846,470. The company has a market capitalization of $7.58 billion, a price-to-earnings ratio of -24.56 and a beta of 3.46. The business has a 50 day simple moving average of $51.58 and a two-hundred day simple moving average of $53.11. The company has a current ratio of 3.31, a quick ratio of 3.15 and a debt-to-equity ratio of 2.96. Tempus AI has a 52-week low of $40.77 and a 52-week high of $104.32.

Analyst Ratings Changes

TEM has been the subject of a number of research analyst reports. Weiss Ratings reissued a “sell (e+)” rating on shares of Tempus AI in a report on Wednesday, June 17th. Jefferies Financial Group initiated coverage on shares of Tempus AI in a research note on Monday, April 13th. They issued an “underperform” rating and a $35.00 target price on the stock. BTIG Research reaffirmed a “buy” rating and set a $80.00 price objective on shares of Tempus AI in a research report on Monday, June 1st. HC Wainwright reissued a “buy” rating on shares of Tempus AI in a report on Friday. Finally, Wolfe Research began coverage on Tempus AI in a report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Nine analysts have rated the stock with a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Tempus AI currently has a consensus rating of “Hold” and a consensus target price of $68.92.

Insider Buying and Selling at Tempus AI

In other news, CEO Eric P. Lefkofsky sold 166,250 shares of the firm’s stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $57.48, for a total transaction of $9,556,050.00. Following the completion of the transaction, the chief executive officer directly owned 8,775,283 shares of the company’s stock, valued at $504,403,266.84. This trade represents a 1.86% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James William Rogers sold 11,529 shares of Tempus AI stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $55.00, for a total value of $634,095.00. Following the transaction, the chief financial officer owned 114,866 shares of the company’s stock, valued at $6,317,630. This represents a 9.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 449,793 shares of company stock worth $23,248,231. Corporate insiders own 24.26% of the company’s stock.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors have recently made changes to their positions in TEM. JPL Wealth Management LLC purchased a new stake in shares of Tempus AI in the third quarter valued at $26,000. Los Angeles Capital Management LLC acquired a new position in Tempus AI in the 4th quarter valued at about $27,000. Harvest Fund Management Co. Ltd purchased a new position in Tempus AI in the 3rd quarter valued at about $38,000. EverSource Wealth Advisors LLC lifted its holdings in Tempus AI by 88.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock valued at $44,000 after purchasing an additional 325 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Tempus AI during the 3rd quarter worth about $48,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.